Perceptive Advisors’s Legend Biotech LEGN Stock Holding History

Perceptive Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-616,141	Closed	-$22.4M	–	116
2022 Q1	$22.4M	Buy	616,141 +427,041	+226%	+$16.9M	0.45%	53
2021 Q4	$8.81M	Buy	+189,100	New	+$9.59M	0.14%	102
2021 Q1	–	Sell	-25,000	Closed	-$704K	–	150
2020 Q4	$704K	Hold	25,000	–	–	0.01%	136
2020 Q3	$772K	Hold	25,000	–	–	0.01%	118
2020 Q2	$1.06M	Buy	+25,000	New	+$977K	0.02%	109

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Perceptive Advisors's LEGN Position: Q2 2022 in Review

Perceptive Advisors sold out of Legend Biotech (LEGN) in Q2 2022, closing a stake of 616,141 shares — an estimated $22.4M sold.

Perceptive Advisors first reported a position in LEGN in Q2 2020 and held it in 5 quarters. The position peaked at $22.4M in Q1 2022. 150 funds tracked by Wall St. Rank hold LEGN as of Q2 2022.

Perceptive Advisors reported no remaining Legend Biotech position as of Q2 2022 after selling out during the quarter.
Perceptive Advisors sold 616,141 Legend Biotech shares in Q2 2022, an estimated $22.4M.
Perceptive Advisors first reported a position in Legend Biotech in Q2 2020 and held it in 5 quarters.
Perceptive Advisors's Legend Biotech position peaked at $22.4M in Q1 2022.
150 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2022.

Based on Perceptive Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.